Addus HomeCare price target raised to $72 from $59 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Addus HomeCare to $72 from $59 following quarterly results to reflect the industry multiples in the space. The analyst reiterates an Outperform rating on the shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.